The luminal I cluster had reduced expression levels of CD8+ genes, lower PD-L1 immune cell or tumor cell expression (“cold tumor”), and a lower response to the anti-PD-L1 atezolizumab [4,5,7,8,24,43]. This evidence concerns the gene CD8A and neoplasm.